Proactive Investors - Run By Investors For Investors

LBT Innovations raises capital and generates sales leads in the US

LBT Innovations Limited (ASX:LBT) chief executive officer Brent Barnes updates Proactive Investors on developments to forge ahead with product sales of its unique APAS Independence technology. 
 
The ground-breaking medical technology company has also raised $5 million on the back of FDA clearance, which will enable the execution of commercialisation plans.
 
Barnes will attend this week's American Society of Microbiology Microbe meeting in San Francisco to further showcase the APAS Independence to the US and global markets.
 
View full LBT profile View Profile

LBT Innovations Ltd Timeline

Newswire
November 30 2016

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use